Conditioned Place Preference Induced by a Combination of l-Dopa and a COMT Inhibitor, Entacapone, in Rats
KATAJAMÄKI, J., A. HONKANEN, T. P. PIEPPONEN, I.-B. LINDÉN, A. ZHARKOVSKY AND L. AHTEE. Conditioned place preference induced by a combination of l -dopa and a COMT inhibitor, entacapone, in rats. PHARMACOL BIOCHEM BEHAV 60(1) 23–26, 1998.—The interaction of dopamine (DA) precursor l-dopa and catecho...
Gespeichert in:
Veröffentlicht in: | Pharmacology, biochemistry and behavior biochemistry and behavior, 1998-05, Vol.60 (1), p.23-26 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 26 |
---|---|
container_issue | 1 |
container_start_page | 23 |
container_title | Pharmacology, biochemistry and behavior |
container_volume | 60 |
creator | Katajamäki, Jaana Honkanen, Aapo Piepponen, T.Petteri Lindén, Inge-Britt Zharkovsky, Alexander Ahtee, Liisa |
description | KATAJAMÄKI, J., A. HONKANEN, T. P. PIEPPONEN, I.-B. LINDÉN, A. ZHARKOVSKY AND L. AHTEE.
Conditioned place preference induced by a combination of l
-dopa and a COMT inhibitor, entacapone, in rats. PHARMACOL BIOCHEM BEHAV
60(1) 23–26, 1998.—The interaction of dopamine (DA) precursor l-dopa and catechol-O-methyltransferase (COMT) inhibitor, entacapone, was examined in rats using conditioned place preference (CPP) paradigm to assess reinforcement, and by measuring DA metabolism in the striatum and the limbic forebrain. Neither l-dopa (100 mg/kg IP) nor entacapone (30 mg/kg IP) alone induced CPP, but in combination they induced significant CPP. Entacapone alone had no effect on limbic or striatal DA concentrations, while it reduced the concentrations of the COMT products 3-methoxytyramine (3-MT), a metabolite reflecting DA release, and homovanillic acid (HVA) in both brain areas. l-dopa elevated limbic but not striatal 3-MT. l-dopa also slightly elevated limbic DA but had no effect on striatal DA concentration. l-Dopa–induced increase of 3-MT was attenuated by entacapone. Our results show for the first time that l-dopa is able to produce CPP in intact animals. This effect may be related to the findings that l-dopa increases synaptic DA concentrations in the limbic areas, and entacapone may enhance this elevation as it prevents the synaptic metabolism of DA. |
doi_str_mv | 10.1016/S0091-3057(97)00394-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17263315</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305797003948</els_id><sourcerecordid>17263315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-bb6543a1ff0e2c989b732358081c497a29f93c76f843daf2e0f9c14f421d34543</originalsourceid><addsrcrecordid>eNqFkF1LHDEUhoO02NX2Jwi5KKWC0-ZrJpMrkfWjgkVp9TqcyQdNmU3WZLbgv2_GXfbWqwTe5z05eRA6oeQbJbT7_psQRRtOWvlVyVNCuBJNf4AWtJe8aamU79Bij3xAR6X8JYQI1slDdKg6WiO1QGGZog1TSNFZ_DCCcfghO--yi_V6G-3G1GB4wYCXaTWECDOLk8djc5nWgCHaObv_-VjpP2EIU8pn-CpOYGBdp57hEPEvmMpH9N7DWNyn3XmMnq6vHpc_mrv7m9vlxV1jBCNTMwxdKzhQ74ljRvVqkJzxtic9NUJJYMorbmTne8EteOaIV4YKLxi1XNTqMfqynbvO6XnjyqRXoRg3jhBd2hRNJes4p20F2y1ociqlflqvc1hBftGU6FmxflWsZ39aSf2qWPe1d7J7YDOsnN23dk5r_nmXQzEw-gzRhLLHGBe862bsfIu5KuNfcFkXE2brNmRnJm1TeGOR_-bqlfQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17263315</pqid></control><display><type>article</type><title>Conditioned Place Preference Induced by a Combination of l-Dopa and a COMT Inhibitor, Entacapone, in Rats</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Katajamäki, Jaana ; Honkanen, Aapo ; Piepponen, T.Petteri ; Lindén, Inge-Britt ; Zharkovsky, Alexander ; Ahtee, Liisa</creator><creatorcontrib>Katajamäki, Jaana ; Honkanen, Aapo ; Piepponen, T.Petteri ; Lindén, Inge-Britt ; Zharkovsky, Alexander ; Ahtee, Liisa</creatorcontrib><description>KATAJAMÄKI, J., A. HONKANEN, T. P. PIEPPONEN, I.-B. LINDÉN, A. ZHARKOVSKY AND L. AHTEE.
Conditioned place preference induced by a combination of l
-dopa and a COMT inhibitor, entacapone, in rats. PHARMACOL BIOCHEM BEHAV
60(1) 23–26, 1998.—The interaction of dopamine (DA) precursor l-dopa and catechol-O-methyltransferase (COMT) inhibitor, entacapone, was examined in rats using conditioned place preference (CPP) paradigm to assess reinforcement, and by measuring DA metabolism in the striatum and the limbic forebrain. Neither l-dopa (100 mg/kg IP) nor entacapone (30 mg/kg IP) alone induced CPP, but in combination they induced significant CPP. Entacapone alone had no effect on limbic or striatal DA concentrations, while it reduced the concentrations of the COMT products 3-methoxytyramine (3-MT), a metabolite reflecting DA release, and homovanillic acid (HVA) in both brain areas. l-dopa elevated limbic but not striatal 3-MT. l-dopa also slightly elevated limbic DA but had no effect on striatal DA concentration. l-Dopa–induced increase of 3-MT was attenuated by entacapone. Our results show for the first time that l-dopa is able to produce CPP in intact animals. This effect may be related to the findings that l-dopa increases synaptic DA concentrations in the limbic areas, and entacapone may enhance this elevation as it prevents the synaptic metabolism of DA.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/S0091-3057(97)00394-8</identifier><identifier>PMID: 9610919</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>3-Methoxytyramine ; Animals ; Biological and medical sciences ; Catechol O-Methyltransferase Inhibitors ; Catechols - administration & dosage ; Conditioned place preference ; Conditioning (Psychology) - drug effects ; Conditioning (Psychology) - physiology ; Corpus Striatum - drug effects ; Corpus Striatum - physiology ; Dopamine ; Dopamine - analogs & derivatives ; Dopamine - metabolism ; Drug Synergism ; Drug toxicity and drugs side effects treatment ; Entacapone ; Enzyme Inhibitors - administration & dosage ; l-Dopa ; Levodopa - administration & dosage ; Limbic System - drug effects ; Limbic System - physiology ; Male ; Medical sciences ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Nitriles ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Reinforcement ; Reinforcement (Psychology) ; Synapses - drug effects ; Synapses - metabolism</subject><ispartof>Pharmacology, biochemistry and behavior, 1998-05, Vol.60 (1), p.23-26</ispartof><rights>1998 Elsevier Science Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-bb6543a1ff0e2c989b732358081c497a29f93c76f843daf2e0f9c14f421d34543</citedby><cites>FETCH-LOGICAL-c420t-bb6543a1ff0e2c989b732358081c497a29f93c76f843daf2e0f9c14f421d34543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0091-3057(97)00394-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2343669$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9610919$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Katajamäki, Jaana</creatorcontrib><creatorcontrib>Honkanen, Aapo</creatorcontrib><creatorcontrib>Piepponen, T.Petteri</creatorcontrib><creatorcontrib>Lindén, Inge-Britt</creatorcontrib><creatorcontrib>Zharkovsky, Alexander</creatorcontrib><creatorcontrib>Ahtee, Liisa</creatorcontrib><title>Conditioned Place Preference Induced by a Combination of l-Dopa and a COMT Inhibitor, Entacapone, in Rats</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>KATAJAMÄKI, J., A. HONKANEN, T. P. PIEPPONEN, I.-B. LINDÉN, A. ZHARKOVSKY AND L. AHTEE.
Conditioned place preference induced by a combination of l
-dopa and a COMT inhibitor, entacapone, in rats. PHARMACOL BIOCHEM BEHAV
60(1) 23–26, 1998.—The interaction of dopamine (DA) precursor l-dopa and catechol-O-methyltransferase (COMT) inhibitor, entacapone, was examined in rats using conditioned place preference (CPP) paradigm to assess reinforcement, and by measuring DA metabolism in the striatum and the limbic forebrain. Neither l-dopa (100 mg/kg IP) nor entacapone (30 mg/kg IP) alone induced CPP, but in combination they induced significant CPP. Entacapone alone had no effect on limbic or striatal DA concentrations, while it reduced the concentrations of the COMT products 3-methoxytyramine (3-MT), a metabolite reflecting DA release, and homovanillic acid (HVA) in both brain areas. l-dopa elevated limbic but not striatal 3-MT. l-dopa also slightly elevated limbic DA but had no effect on striatal DA concentration. l-Dopa–induced increase of 3-MT was attenuated by entacapone. Our results show for the first time that l-dopa is able to produce CPP in intact animals. This effect may be related to the findings that l-dopa increases synaptic DA concentrations in the limbic areas, and entacapone may enhance this elevation as it prevents the synaptic metabolism of DA.</description><subject>3-Methoxytyramine</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Catechol O-Methyltransferase Inhibitors</subject><subject>Catechols - administration & dosage</subject><subject>Conditioned place preference</subject><subject>Conditioning (Psychology) - drug effects</subject><subject>Conditioning (Psychology) - physiology</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - physiology</subject><subject>Dopamine</subject><subject>Dopamine - analogs & derivatives</subject><subject>Dopamine - metabolism</subject><subject>Drug Synergism</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Entacapone</subject><subject>Enzyme Inhibitors - administration & dosage</subject><subject>l-Dopa</subject><subject>Levodopa - administration & dosage</subject><subject>Limbic System - drug effects</subject><subject>Limbic System - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Nitriles</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reinforcement</subject><subject>Reinforcement (Psychology)</subject><subject>Synapses - drug effects</subject><subject>Synapses - metabolism</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LHDEUhoO02NX2Jwi5KKWC0-ZrJpMrkfWjgkVp9TqcyQdNmU3WZLbgv2_GXfbWqwTe5z05eRA6oeQbJbT7_psQRRtOWvlVyVNCuBJNf4AWtJe8aamU79Bij3xAR6X8JYQI1slDdKg6WiO1QGGZog1TSNFZ_DCCcfghO--yi_V6G-3G1GB4wYCXaTWECDOLk8djc5nWgCHaObv_-VjpP2EIU8pn-CpOYGBdp57hEPEvmMpH9N7DWNyn3XmMnq6vHpc_mrv7m9vlxV1jBCNTMwxdKzhQ74ljRvVqkJzxtic9NUJJYMorbmTne8EteOaIV4YKLxi1XNTqMfqynbvO6XnjyqRXoRg3jhBd2hRNJes4p20F2y1ociqlflqvc1hBftGU6FmxflWsZ39aSf2qWPe1d7J7YDOsnN23dk5r_nmXQzEw-gzRhLLHGBe862bsfIu5KuNfcFkXE2brNmRnJm1TeGOR_-bqlfQ</recordid><startdate>19980501</startdate><enddate>19980501</enddate><creator>Katajamäki, Jaana</creator><creator>Honkanen, Aapo</creator><creator>Piepponen, T.Petteri</creator><creator>Lindén, Inge-Britt</creator><creator>Zharkovsky, Alexander</creator><creator>Ahtee, Liisa</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope></search><sort><creationdate>19980501</creationdate><title>Conditioned Place Preference Induced by a Combination of l-Dopa and a COMT Inhibitor, Entacapone, in Rats</title><author>Katajamäki, Jaana ; Honkanen, Aapo ; Piepponen, T.Petteri ; Lindén, Inge-Britt ; Zharkovsky, Alexander ; Ahtee, Liisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-bb6543a1ff0e2c989b732358081c497a29f93c76f843daf2e0f9c14f421d34543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>3-Methoxytyramine</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Catechol O-Methyltransferase Inhibitors</topic><topic>Catechols - administration & dosage</topic><topic>Conditioned place preference</topic><topic>Conditioning (Psychology) - drug effects</topic><topic>Conditioning (Psychology) - physiology</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - physiology</topic><topic>Dopamine</topic><topic>Dopamine - analogs & derivatives</topic><topic>Dopamine - metabolism</topic><topic>Drug Synergism</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Entacapone</topic><topic>Enzyme Inhibitors - administration & dosage</topic><topic>l-Dopa</topic><topic>Levodopa - administration & dosage</topic><topic>Limbic System - drug effects</topic><topic>Limbic System - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Nitriles</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reinforcement</topic><topic>Reinforcement (Psychology)</topic><topic>Synapses - drug effects</topic><topic>Synapses - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katajamäki, Jaana</creatorcontrib><creatorcontrib>Honkanen, Aapo</creatorcontrib><creatorcontrib>Piepponen, T.Petteri</creatorcontrib><creatorcontrib>Lindén, Inge-Britt</creatorcontrib><creatorcontrib>Zharkovsky, Alexander</creatorcontrib><creatorcontrib>Ahtee, Liisa</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katajamäki, Jaana</au><au>Honkanen, Aapo</au><au>Piepponen, T.Petteri</au><au>Lindén, Inge-Britt</au><au>Zharkovsky, Alexander</au><au>Ahtee, Liisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conditioned Place Preference Induced by a Combination of l-Dopa and a COMT Inhibitor, Entacapone, in Rats</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>1998-05-01</date><risdate>1998</risdate><volume>60</volume><issue>1</issue><spage>23</spage><epage>26</epage><pages>23-26</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>KATAJAMÄKI, J., A. HONKANEN, T. P. PIEPPONEN, I.-B. LINDÉN, A. ZHARKOVSKY AND L. AHTEE.
Conditioned place preference induced by a combination of l
-dopa and a COMT inhibitor, entacapone, in rats. PHARMACOL BIOCHEM BEHAV
60(1) 23–26, 1998.—The interaction of dopamine (DA) precursor l-dopa and catechol-O-methyltransferase (COMT) inhibitor, entacapone, was examined in rats using conditioned place preference (CPP) paradigm to assess reinforcement, and by measuring DA metabolism in the striatum and the limbic forebrain. Neither l-dopa (100 mg/kg IP) nor entacapone (30 mg/kg IP) alone induced CPP, but in combination they induced significant CPP. Entacapone alone had no effect on limbic or striatal DA concentrations, while it reduced the concentrations of the COMT products 3-methoxytyramine (3-MT), a metabolite reflecting DA release, and homovanillic acid (HVA) in both brain areas. l-dopa elevated limbic but not striatal 3-MT. l-dopa also slightly elevated limbic DA but had no effect on striatal DA concentration. l-Dopa–induced increase of 3-MT was attenuated by entacapone. Our results show for the first time that l-dopa is able to produce CPP in intact animals. This effect may be related to the findings that l-dopa increases synaptic DA concentrations in the limbic areas, and entacapone may enhance this elevation as it prevents the synaptic metabolism of DA.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9610919</pmid><doi>10.1016/S0091-3057(97)00394-8</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-3057 |
ispartof | Pharmacology, biochemistry and behavior, 1998-05, Vol.60 (1), p.23-26 |
issn | 0091-3057 1873-5177 |
language | eng |
recordid | cdi_proquest_miscellaneous_17263315 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | 3-Methoxytyramine Animals Biological and medical sciences Catechol O-Methyltransferase Inhibitors Catechols - administration & dosage Conditioned place preference Conditioning (Psychology) - drug effects Conditioning (Psychology) - physiology Corpus Striatum - drug effects Corpus Striatum - physiology Dopamine Dopamine - analogs & derivatives Dopamine - metabolism Drug Synergism Drug toxicity and drugs side effects treatment Entacapone Enzyme Inhibitors - administration & dosage l-Dopa Levodopa - administration & dosage Limbic System - drug effects Limbic System - physiology Male Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Nitriles Pharmacology. Drug treatments Rats Rats, Wistar Reinforcement Reinforcement (Psychology) Synapses - drug effects Synapses - metabolism |
title | Conditioned Place Preference Induced by a Combination of l-Dopa and a COMT Inhibitor, Entacapone, in Rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T05%3A06%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conditioned%20Place%20Preference%20Induced%20by%20a%20Combination%20of%20l-Dopa%20and%20a%20COMT%20Inhibitor,%20Entacapone,%20in%20Rats&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Katajam%C3%A4ki,%20Jaana&rft.date=1998-05-01&rft.volume=60&rft.issue=1&rft.spage=23&rft.epage=26&rft.pages=23-26&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/S0091-3057(97)00394-8&rft_dat=%3Cproquest_cross%3E17263315%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17263315&rft_id=info:pmid/9610919&rft_els_id=S0091305797003948&rfr_iscdi=true |